RIPK1 and amyotrophic lateral sclerosis: Ripk1/Ripk3 associated with marked neuroinflammation in animal models of diseases such as multiple sclerosis (56), amyotrophic lateral sclerosis (57) and Alzheimer’s disease (34) and their inhibition improved the disease phenotype.